Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
8.13 INR
3.14 B INR
21.76 B INR
204.32 M
About MARKSANS PHARMA LTD
Sector
Industry
CEO
Mark Bosco Saldanha
Website
Headquarters
Mumbai
Founded
1992
ISIN
INE750C01026
FIGI
BBG000D7VQM3
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio includes tablets, hard capsules, soft gelatin capsules, oral liquids, and ointments. It operates through the following geographical segments: US and North America, Europe and UK, Australia and New Zealand, India, and Rest of World. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.
50 SMA Rising - Swing TradeDisclaimer: I am not a Sebi registered adviser.
This Idea is publish purely for educational purpose only before investing in any stocks please take advise from your financial adviser.
50 SMA Rising strategy. Suitable for Swing Trading Initial Stop loss lowest of last 2 candles and keep trailing wi
MARKSANS PHARMA LTD S/R Support and Resistance Levels:
Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
Volume Breakout - Swing TradeDisclaimer: I am not a Sebi registered adviser.
This Idea is publish purely for educational purpose only before investing in any stocks please take advise from your financial adviser.
Volume Breakout. Stock has give Breakout with Volume. Keep in watch list. Buy above the high. Suitable for Swing Tr
Cup And Handle formation in Marksans Pharma on Monthly CandlesA Cup and Handle Pattern seems to be forming in Marksans Pharma on Monthly basis which explains the recent up move.
Good Buying Price would be at 166 (If Someone has bought it at this price can hold it)
Other Buying Opportunity can be Below 260
SL can be marked at 106
Targets Can be
Targe
Trending up!The stock continues to go up, hoping to see new highs given that the company has got approvals from UK/US regulatory. I'm in for a swing 8 to 12% gain in the short term.
I'm not SEBI certified advisor, my posts are just my ideas or my trades I entered in. It may or may not work, I trade with a stri
MARKSANSWeekly Breakout Done.
Accumulation Done.
Huge Volumes.
Good for Short Term.
Do Like ,Comment , Follow for regular Updates...
Keep Learning ,Keep Earning...
Disclaimer : This is not a Buy or Sell recommendation. I am not SEBI Registered. Please consult your financial advisor before making any inv
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MARKSANS is 211.01 INR — it has increased by 5.89% in the past 24 hours. Watch MARKSANS PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange MARKSANS PHARMA LTD stocks are traded under the ticker MARKSANS.
MARKSANS stock has fallen by −11.77% compared to the previous week, the month change is a 1.27% rise, over the last year MARKSANS PHARMA LTD has showed a 33.47% increase.
We've gathered analysts' opinions on MARKSANS PHARMA LTD future price: according to them, MARKSANS price has a max estimate of 323.00 INR and a min estimate of 323.00 INR. Watch MARKSANS chart and read a more detailed MARKSANS PHARMA LTD stock forecast: see what analysts think of MARKSANS PHARMA LTD and suggest that you do with its stocks.
MARKSANS reached its all-time high on Dec 2, 2024 with the price of 358.70 INR, and its all-time low was 1.30 INR and was reached on May 18, 2012. View more price dynamics on MARKSANS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MARKSANS stock is 3.65% volatile and has beta coefficient of 1.94. Track MARKSANS PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is MARKSANS PHARMA LTD there?
Today MARKSANS PHARMA LTD has the market capitalization of 93.15 B, it has decreased by −12.07% over the last week.
Yes, you can track MARKSANS PHARMA LTD financials in yearly and quarterly reports right on TradingView.
MARKSANS PHARMA LTD is going to release the next earnings report on Jun 2, 2025. Keep track of upcoming events with our Earnings Calendar.
MARKSANS PHARMA LTD revenue for the last quarter amounts to 6.82 B INR, despite the estimated figure of 6.65 B INR. In the next quarter, revenue is expected to reach 6.96 B INR.
MARKSANS net income for the last quarter is 1.05 B INR, while the quarter before that showed 967.16 M INR of net income which accounts for 8.11% change. Track more MARKSANS PHARMA LTD financial stats to get the full picture.
Yes, MARKSANS dividends are paid annually. The last dividend per share was 0.60 INR. As of today, Dividend Yield (TTM)% is 0.29%. Tracking MARKSANS PHARMA LTD dividends might help you take more informed decisions.
MARKSANS PHARMA LTD dividend yield was 0.40% in 2023, and payout ratio reached 8.67%. The year before the numbers were 0.71% and 7.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has 1.42 K employees. See our rating of the largest employees — is MARKSANS PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARKSANS PHARMA LTD EBITDA is 5.13 B INR, and current EBITDA margin is 21.16%. See more stats in MARKSANS PHARMA LTD financial statements.
Like other stocks, MARKSANS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKSANS PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MARKSANS PHARMA LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MARKSANS PHARMA LTD stock shows the buy signal. See more of MARKSANS PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.